Results 11 to 20 of about 257,026 (346)

Recent advances in combined modality therapy. [PDF]

Oncologist, 2010
This review highlights the recent clinical data in support of newer generation cytotoxic chemotherapies and systemic targeted agents in combination with radiation ...
Mierzwa ML, Nyati MK, Morgan MA, Lawrence TS.   +3 more
europepmc   +8 more sources

Editorial: Developing combined modality therapy with mitochondria-targeting strategy [PDF]

Frontiers in Oncology, 2023
Yong Teng, Yong Teng
doaj   +2 more sources

Case Report: Effective management of residual glioblastoma with combined modality therapy [PDF]

Frontiers in Oncology
Glioblastoma (GBM) is an aggressive primary brain tumor with a poor prognosis, often characterized by rapid progression and resistance to conventional therapies.
Heng-Jui Chang, Chiao-Hsu Ke, Yu-Shan Wang, Yu-Shan Wang, Yu-Cheng Kuo, Yu-Cheng Kuo   +5 more
doaj   +2 more sources

Combined Modality Therapy of Gemcitabine and Radiation [PDF]

The Oncologist, 2005
Abstract Learning Objectives After completing this course, the reader will be able to: List the advantages of combination chemotherapy and radiotherapy. Explain the rationale for doing in vitro research in the radiochemotherapy field.
Bea Pauwels, A.E.C. Korst, Filip Lardon, Jan B. Vermorken   +3 more
openalex   +5 more sources

Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China. [PDF]

BMC Cancer, 2021
Xie L, Xu J, Li X, Zhou Z, Zhuang H, Sun X, Liu K, Liu X, Sun K, Wu Y, Gu J, Guo W.   +11 more
europepmc   +3 more sources

Management of Locally Advanced Esophageal Cancer

Journal of Nepal Medical Association, 2021
Esophageal cancer is diagnosed usually at a locally advanced stage. Surgery alone has less optimal results and a multimodality approach has been established as the standard of care for cII-III stages of esophageal cancer.
Binay Thakur, Mukti Devkota, Manish Chaudhary   +2 more
doaj   +3 more sources

Combined modality therapy for exsudative form of age-related macular degeneration

Biomedical Photonics, 2013
Treatment outcomes in patients with age-related vascular degeneration due to formation of subretinal neovascular membrane (SNM) of two groups: photodynamic therapy (PDT) with Photosens alone (18 patients) and in combination with anti-VEGF therapy with ...
М. V. Budzinskaya, I. V. Gurova, I. V. Schegoleva, V. B. Loschenov, S. А. Shevchik, S. G. Kuzjmin, G. N. Vorogtsov   +6 more
doaj   +4 more sources

Improved Management of the Advanced Nonseminomatous Testis Cancer

Revista Brasileira de Cancerologia, 2023
With the VAB-6 program about 90% (54/59) of patients with stage III and bulky stage II disease achieved complete remission and eighty percent remain free of disease.
Davor Vugrin
doaj   +1 more source

Medulloblastoma: Results with combined modality therapy

International Journal of Radiation Oncology*Biology*Physics, 1989
The results of treatment of posterior fossa (PF) medulloblastomas treated at UCSF between 1966 and 1987 were analyzed. 65 patients (pts) were treated postoperatively with craniospinal radiation therapy (CS XRT). The PF dose was 54 Gy. Initially spinal doses of 30-40 Gy, cranial doses of 40-50 Gy were given. Late sequelae were noted.
F. Halberg, W. Warm, L. Fippin, Margaret Edwards, Victor A. Levin, Robert S. Davis, M. Prados, C. Wilson   +7 more
openalex   +3 more sources

Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma. [PDF]

Pharmaceutics, 2019
Zhu H, Han W, Gan Y, Li Q, Li X, Shao L, Zhu D, Guo H.   +7 more
europepmc   +3 more sources